Generic drug
Succinylcholine price, strengths & recalls
Succinylcholine has no weekly pharmacy acquisition cost. 23 manufacturers make it. It is in shortage (being discontinued). 4 recalls are ongoing. Its official label last changed on February 10, 2026.
Being discontinued4 open recallsGenericSuccinylcholine price by strength
What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 20 mg/mL injection | Not priced this week | |||
| 20 mg/mL, 10 mL prefilled syringe | Not priced this week | |||
| 20 mg/mL, 5 mL prefilled syringe | Not priced this week | |||
Supply status: shortages & recalls
Shortages
- Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 45 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Succinylcholine
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use SUCCINYLCHOLINE CHLORIDE INJECTION safely and effectively. See full prescribing information for SUCCINYLCHOLINE CHLORIDE INJECTION.SUCCINYLCHOLINE CHLORIDE injection, for intravenous or intramuscular use Initial U.S. Approval: 1952
WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS
Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after the administration of succinylcholine to apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy, most frequently Duchenne muscular dystrophy [see Warnings and Precautions (5.1)].
When a healthy appearing pediatric patient develops cardiac arrest within minutes after administration of Succinylcholine Chloride Injection, not felt to be due to inadequate ventilation, oxygenation or anesthetic overdose, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently [see Warnings and Precautions (5.1)].
Reserve the use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, e.g., laryngospasm, difficult airway, full stomach, or for intramuscular use when a suitable vein is inaccessible [see Warnings and Precautions (5.1)].
WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS
See full prescribing information for complete boxed warning.
Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after use in apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy. (5.1)
When a healthy-appearing pediatric patient develops cardiac arrest soon after administration of Succinylcholine Chloride Injection, not felt to be due to other causes, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently. (5.1)
Reserve use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, or for intramuscular use when a suitable vein is inaccessible. (5.1)
Recent major changes (as listed on the label)
Contraindications (4)
| 11/2022 |
Warnings and Precautions, Malignant Hyperthermia (5.5)
| 11/2022 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 19 approved generic applications on the market
Succinylcholine questions
Is succinylcholine in shortage?
Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.
Has succinylcholine been recalled?
45 recalls on record, 4 ongoing. Recalls name specific lots - check yours.
When did the succinylcholine label last change?
The official label was last updated on February 10, 2026 (version 1). See what changed.
Talk about succinylcholine
No comments yet. Questions, tips, what worked for you - start the conversation.